Results 201 to 210 of about 79,283 (266)

Longitudinal Monocyte Subset Dynamics as Biomarker in Adult Histiocytosis: Association With Mutational Status, Kinase Inhibitor Exposure and Relapse Risk

open access: yes
Hematological Oncology, Volume 44, Issue 5, September 2026.
Jerome Razanamahery   +10 more
wiley   +1 more source

Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer. [PDF]

open access: yesBreast Cancer Res Treat
Prasath V   +23 more
europepmc   +1 more source

MEK inhibitor PD0325901 upregulates CD34 expression in endothelial cells via inhibition of ERK phosphorylation. [PDF]

open access: yesRegen Ther
Hosoda C   +7 more
europepmc   +1 more source

TANC1::HTRA1 fusion in schwannomas

open access: yes
Brain Pathology, Volume 36, Issue 5, September 2026.
Ilay Caliskan   +3 more
wiley   +1 more source

Novel BRAF fusion in Erdheim–Chester disease with pulmonary manifestations: Importance of RNA‐based testing and response to MEK inhibition

open access: yes
Histopathology, Volume 89, Issue 3, Page 558-561, September 2026.
Igor Odintsov   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy